Overview
Andrew Ming practices practicing medicine in Sydney, Australia.
His clinical expertise encompasses Frey's Syndrome, Squamous Cell Skin Carcinoma, Hyperhidrosis, and Bullous Pemphigoid.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Andrew Ming
Is Andrew Ming a top-rated expert for Frey's Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Andrew Ming is classified as an Experienced expert for Frey's Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Andrew Ming participate in research or clinical trials?
Yes. Andrew Ming has published 10 articles and abstracts on conditions like Frey's Syndrome. You can view a list of Andrew Ming's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bullous PemphigoidMr. Ming isExperienced. Learn about Bullous Pemphigoid.
- Frey's SyndromeMr. Ming isExperienced. Learn about Frey's Syndrome.
- HyperhidrosisMr. Ming isExperienced. Learn about Hyperhidrosis.
- Squamous Cell Skin CarcinomaMr. Ming isExperienced. Learn about Squamous Cell Skin Carcinoma.